Clinical effects of digoxin on sinus node and atrioventricular node function after pharmacologic autonomic blockade

Area of Science:

• Cardiology
• Electrophysiology
• Pharmacology

Background:

• Digoxin is a cardiac glycoside used to treat heart failure and arrhythmias.
• Its effects on cardiac conduction, particularly the sinus node and atrioventricular node, require further elucidation.
• Understanding these effects is crucial for safe and effective digoxin use.

Purpose of the Study:

• To investigate the direct effects of digoxin on sinus node and atrioventricular node function.
• To determine whether digoxin's observed electrophysiologic effects are intrinsic or mediated by the autonomic nervous system.

Main Methods:

• Electrophysiologic studies were conducted in 18 patients with normal intrinsic heart rates.
• Studies were performed during basal state and after autonomic blockade (propranolol and atropine).
• Digoxin was administered intravenously to achieve full digitalization.

Main Results:

• Digoxin significantly prolonged sinus cycle length and AH interval during basal state (p < 0.01).
• After autonomic blockade, digoxin did not significantly alter intrinsic sinus node function (SCL, cSNRT, SCT) or AV node function (AH interval, AVNRP).
• These findings indicate that digoxin's depressant effects are primarily mediated via autonomic pathways.

Conclusions:

• Therapeutic doses of digoxin do not intrinsically depress sinus node or atrioventricular node function.
• The observed electrophysiologic slowing effects of digoxin are mediated through the autonomic nervous system.
• This suggests a nuanced understanding of digoxin's electrophysiologic profile in clinical practice.